The huge potential of stem cells in therapeutic paradigms is truly amazing. A recent pioneering study in kidney transplant patients showed that mesenchymal stem cells act as a powerful anti-rejection drug. This exciting result may eliminate the life-long need for immunosuppressive drugs in lower the incidence of acute organ rejection.
Organ donor stem cells helped five patients with kidney transplants wean themselves off organ rejection drugs within a year of their operation, BBC News reports.
Stem cells are showing some great versatility in preclinical and early-stage clinical research, as a treatment for liver damage, heart attacks and also a potential fertility drug, among other indications.
Click here to read the full report
To understand different types of stem cells, the mode of action of stem cells and impact of recent advances on the commercial market join us for the 3 Day MBA course in Stem Cells
Download the brochure to find out more